Depressive Disorders - Gambia | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$5.42m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.59%, resulting in a market volume of US$5.87m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$25.09 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Gambia is experiencing steady growth due to increasing customer preferences for mental health services and the implementation of local initiatives to address mental health issues. Customer preferences in the Depressive Disorders market in Gambia are shifting towards seeking professional help and treatment for mental health conditions. This is driven by a growing awareness and understanding of mental health issues, as well as a reduction in the stigma associated with seeking help for mental health problems. Additionally, the availability of mental health services and treatment options has improved, making it easier for individuals to access the care they need. As a result, more people are seeking diagnosis and treatment for depressive disorders in Gambia.Trends in the market show an increased demand for mental health services and treatment options in Gambia. This is reflected in the growing number of mental health clinics and facilities that have opened in the country. These clinics offer a range of services, including counseling, therapy, and medication management, to help individuals manage their depressive disorders. Furthermore, there has been an increase in the number of mental health professionals, such as psychiatrists and psychologists, who are trained to diagnose and treat depressive disorders. This has led to improved access to specialized care for individuals with depressive disorders in Gambia.Local special circumstances in Gambia contribute to the development of the Depressive Disorders market. The country has a relatively high prevalence of depressive disorders, which is attributed to a combination of genetic, environmental, and socio-cultural factors. Additionally, Gambia has a young population, with a significant percentage of the population being under the age of 30. This demographic trend has implications for the Depressive Disorders market, as younger individuals are more likely to seek help for mental health issues and are more open to discussing their mental health concerns.Underlying macroeconomic factors also play a role in the development of the Depressive Disorders market in Gambia. The country has experienced economic growth in recent years, which has led to an increase in disposable income and improved access to healthcare services. This has made it easier for individuals to afford mental health services and treatment for depressive disorders. Additionally, the government of Gambia has recognized the importance of mental health and has taken steps to improve mental health services and support. This includes the development of national mental health policies and the allocation of resources to mental health programs.In conclusion, the Depressive Disorders market in Gambia is growing due to increasing customer preferences for mental health services, the implementation of local initiatives to address mental health issues, and underlying macroeconomic factors. As awareness and understanding of mental health issues continue to improve, it is expected that the demand for mental health services and treatment options will continue to grow in Gambia.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.